Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery
Recruiting
N/A
Interventional Study
Post Partum Hemorrhage
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 50
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 160 (estimated)
- Sponsor
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to compare 2 medications that are commonly used to prevent excess uterine bleeding (postpartum hemorrhage, or PPH) following cesarean delivery (CD), oxytocin and carbetocin. Most of the trials evaluating the preventative role of oxytocin and carbetocin after CD have focused on patient with low-risk of PPH.
This trial will focus on patients that are at increased risk of P…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria - Any one or more of the risk factors for uterine atony:
* Overdistended uterus due to:
* Polyhydramnios (amniotic fluid index \>24 cm)
* Fetal macrosomia reported on prenatal ultrasound \>90th centile or \> 4000 gm
* Multiple gestation
* History of uterine atony/PPH (docu…
Contacts